EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aberrant monocytopoiesis drives granuloma development in sarcoidosis

Ryosuke Hiranuma, Ryota Sato, Kiyoshi Yamaguchi, Satoshi Nakamizo iD, Kenichi Asano, Takuma Shibata, Ryutaro Fukui, Yoichi Furukawa, Kenji Kabashima iD, Kensuke Miyake

International Immunology · 09.03.2024 · 36 (4) · 183-196

DOI: 10.1093/intimm/dxad054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunology, online erschienen am 26.12.2023. Verfasst von Ryosuke Hiranuma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Innate Immunity, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Macrophages, Sarcoidosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Core Research for Evolutional Science and Technology, Institute of Medical Science at the University of Tokyo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In sarcoidosis, granulomas develop in multiple organs including the liver and lungs. Although mechanistic target of rapamycin complex 1 (mTORC1) activation in macrophages drives granuloma development in sarcoidosis by enhancing macrophage proliferation, little is known about the macrophage subsets that proliferate and mature into granuloma macrophages. Here, we show that aberrantly increased monocytopoiesis gives rise to granulomas in a sarcoidosis model, in which Tsc2, a negative regulator of mTORC1, is conditionally deleted in CSF1R-expressing macrophages (Tsc2csf1rΔ mice). In Tsc2csf1rΔ mice, common myeloid progenitors (CMPs), granulocyte-monocyte progenitors (GMPs), common monocyte progenitors / monocyte progenitors (cMoPs / MPs), inducible monocyte progenitors (iMoPs), and Ly6Cint CX3CR1low CD14− immature monocytes (iMOs), but not monocyte-dendritic cell progenitors (MDPs) and common dendritic cell progenitors (CDPs), accumulated and proliferated in the spleen. Consistent with this, monocytes, neutrophils, and neutrophil-like monocytes increased in the spleens of Tsc2csf1rΔ mice, whereas dendritic cells did not. The adoptive transfer of splenic iMOs into wild-type mice gave rise to granulomas in the liver and lungs. In these target organs, iMOs matured into Ly6Chi classical monocytes/macrophages (cMOs). Giant macrophages (gMAs) also accumulated in the liver and lungs, which were similar to granuloma macrophages in expression of cell surface markers such as MerTK and SLAMF7. Furthermore, the gMA-specific genes were expressed in human macrophages from sarcoidosis skin lesions. These results suggest that mTORC1 drives granuloma development by promoting the proliferation of monocyte/neutrophil progenitors and iMOs predominantly in the spleen, and that proliferating iMOs mature into cMOs and then gMAs to give rise to granuloma after migration into the liver and lungs in sarcoidosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesSarcoidosisMiceHumansAnimalsCell DifferentiationMonocytesGranulomaMechanistic Target of Rapamycin Complex 1

Stichwörter der Autor:innen

mTORC1macrophage

Substanzen

Mechanistic Target of Rapamycin Complex 1

Autor:innen und Institutionen

  • Division of Innate Immunity, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Division of Clinical Genome Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Alliance Laboratory for Advanced Medical Research, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Laboratory of Immune Regulation, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan.
  • Skin Research Institute of Singapore (SRIS) and A*STAR Skin Research Labs (A*SRL), Agency for Science, Technology, and Research (A*STAR), 8A Biomedical Grove, IMMUNOS Building, Biopolis, Singapore.

ORCID-Profile: Satoshi Nakamizo, Kenji Kabashima

Förderung

  • Japan Society for the Promotion of Science
  • Core Research for Evolutional Science and Technology
  • Institute of Medical Science at the University of Tokyo
  • Japan Agency for Medical Research and Development
  • Takeda Science Foundation
  • Daiichi Sankyo Foundation of Life Science
  • Mochida Memorial Foundation for Medical and Pharmaceutical Research

Zitieren

APA

Hiranuma, R., Sato, R., Yamaguchi, K., Nakamizo, S., Asano, K., Shibata, T., Fukui, R., Furukawa, Y., Kabashima, K., & Miyake, K. (2024). Aberrant monocytopoiesis drives granuloma development in sarcoidosis. International Immunology, 36(4), 183-196. https://doi.org/10.1093/intimm/dxad054

Vancouver

Hiranuma R, Sato R, Yamaguchi K, Nakamizo S, Asano K, Shibata T, et al. Aberrant monocytopoiesis drives granuloma development in sarcoidosis. International Immunology. 2024;36(4):183-196. doi:10.1093/intimm/dxad054

BibTeX
@article{Hiranuma2024,
  author = {Hiranuma, Ryosuke and Sato, Ryota and Yamaguchi, Kiyoshi and Nakamizo, Satoshi and Asano, Kenichi and Shibata, Takuma and Fukui, Ryutaro and Furukawa, Yoichi and Kabashima, Kenji and Miyake, Kensuke},
  title = {Aberrant monocytopoiesis drives granuloma development in sarcoidosis},
  journal = {International Immunology},
  year = {2024},
  volume = {36},
  number = {4},
  pages = {183--196},
  doi = {10.1093/intimm/dxad054}
}
Kostenlos starten →